
Upstream Bio Investor Relations Material
Latest events

Q1 2025
6 May, 2025

Q4 2024
12 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Upstream Bio Inc
Access all reports
Upstream Bio Inc. is a U.S.-based biotechnology company focused on developing innovative therapies for inflammatory and allergic diseases. The company’s research is centered on targeting key biological pathways involved in immune response, with the goal of creating treatments that address unmet medical needs in conditions such as asthma and other chronic inflammatory disorders. Upstream Bio’s pipeline includes investigational drugs aimed at modulating immune mechanisms to improve patient outcomes and quality of life. Upstream Bio Inc. is headquartered in Waltham, Massachusetts.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
UPB
Country
🇺🇸 United States